Early detection with MRI of incomplete treatment of spine metastases after percutaneous cryoablation.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 09 10 2018
accepted: 24 01 2019
revised: 27 12 2018
pubmed: 17 3 2019
medline: 18 12 2019
entrez: 17 3 2019
Statut: ppublish

Résumé

To evaluate post-ablation MRI for the detection of incompletely treated spinal osseous metastases (SOM) after cryoablation and to propose a post-ablation imaging classification. After IRB consent, all patients treated with cryoablation of SOM between 2011 and 2017 having at least 1-year minimum follow-up and a spine MRI within 4 months after cryoablation were retrospectively included. A classification of MRI images into four types was set up. The primary endpoint of our study was to assess the diagnostic performance of the post-ablation MRI. The secondary endpoints were the 1-year complete treatment rate (CTR) and complications. Fifty-four SOMs in 39 patients were evaluated. Post-ablation MRI was performed with a median delay of 25 days after cryoablation. Images were evaluated by two independent readers according to the pre-established image classification. Sensitivity and specificity for the detection of residual tumor were 77.3% (95%CI = 62.2-88.5) and 85.9% (95%CI = 75.0-93.4), respectively. Types I, II, III, and IV of the classification were associated with a 1-year complete treatment in 100%, 83.3%, 35.7%, and 10% of cases, respectively. The 1-year CTR was 59.3% for all 54 metastases, and 95.8% for metastases measuring less than 25 mm and at least 2 mm or more away from the spinal canal. Two grade 3 and two grade 2 adverse events according to the CTCAE were reported. MRI after cryoablation is useful for the evaluation of the ablation efficacy. The classification of post-cryoablation MRI provides reliable clues for the prediction of complete treatment at 1 year. • MRI performed 25 days after cryoablation is useful to evaluate the efficacy. • The proposed classification provides a reliable clue for complete cryoablation. • Percutaneous cryoablation of spinal metastases is highly effective for lesions less than 25 mm in diameter and of at least 2 mm away from the spinal canal.

Identifiants

pubmed: 30877460
doi: 10.1007/s00330-019-06040-y
pii: 10.1007/s00330-019-06040-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5655-5663

Références

J Neurosurg Spine. 2012 Apr;16(4):379-86
pubmed: 22225488
Cancer. 1975 Aug;36(2):590-4
pubmed: 1157021
AJNR Am J Neuroradiol. 2016 Jan;37(1):189-95
pubmed: 26427837
Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):659-63
pubmed: 25017149
Endocrine. 2018 Mar;59(3):547-554
pubmed: 29305799
Ann Oncol. 2015 May;26(5):987-991
pubmed: 25688058
Eur Radiol. 2013 Jul;23(7):1986-97
pubmed: 23455764
Lancet Oncol. 2012 Apr;13(4):395-402
pubmed: 22285199
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s
pubmed: 17062708
Lancet Oncol. 2015 Dec;16(16):e595-603
pubmed: 26678212
Radiology. 2011 Jan;258(1):270-6
pubmed: 21045185
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):484-90
pubmed: 18234445
Eur Radiol. 1998;8(8):1345-51
pubmed: 9853211
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Eur Radiol. 2014 Aug;24(8):1971-80
pubmed: 24859596
Eur Radiol. 2018 Oct;28(10):4146-4150
pubmed: 29651762
Eur J Radiol. 2009 Mar;69(3):567-73
pubmed: 18191356
AJR Am J Roentgenol. 2000 Dec;175(6):1619-25
pubmed: 11090390
Psychol Bull. 1968 Oct;70(4):213-20
pubmed: 19673146
J Clin Oncol. 2009 Oct 20;27(30):5075-9
pubmed: 19738130
Eur Radiol. 2011 Dec;21(12):2604-17
pubmed: 21887484
Semin Musculoskelet Radiol. 2011 Apr;15(2):125-34
pubmed: 21500132
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Ann Oncol. 2011 Feb;22(2):307-14
pubmed: 20624786
J Neurosurg Spine. 2017 Oct;27(4):428-435
pubmed: 28708043
J Nucl Med. 2010 Aug;51(8):1213-8
pubmed: 20660382

Auteurs

Guillaume Gravel (G)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France. guillaume.gravel@gustaveroussy.fr.

Lambros Tselikas (L)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Benjamin Moulin (B)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Steven Yevich (S)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Eric Baudin (E)

Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Antoine Hakime (A)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Salma Moalla (S)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.
Department of Diagnostic Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Fadila Mihoubi (F)

Department of Diagnostic Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Corinne Balleyguier (C)

Department of Diagnostic Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Thierry de Baere (T)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Frederic Deschamps (F)

Department of Interventional Radiology, Gustave Roussy Cancer Center, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH